Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6746359 | 7409573 | F | 6746359-1 | 20100519 | 20100526 | EXP | TCI2010A01781 | TAKEDA PHARMACEUTICALS NORTH AMERICA. | 68 | YR | F | N | 20100525 | JAPAN |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6746359 | 1013771498 | PS | ACTOS | 1 | ORAL | 15 MG (15 MG, 1 D), PER ORAL | Y | D | 21073 | ||
| 6746359 | 1013796085 | SS | PHENYTOIN | 1 | 200 MG (200 MG,1 D) | ||||||
| 6746359 | 1013796087 | SS | GLIMEPIRIDE | 1 | ORAL | 1 MG (1 MG, 1 ) PER ORAL |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6746359 | 1013771498 | TYPE 2 DIABETES MELLITUS |
| 6746359 | 1013796087 | TYPE 2 DIABETES MELLITUS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6746359 | RI |
Reactions reported
| Event ID | PT |
|---|---|
| 6746359 | DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
| 6746359 | GENERALISED ERYTHEMA |
| 6746359 | HEPATIC ENZYME INCREASED |
| 6746359 | PRURITUS |
| 6746359 | PYREXIA |
| 6746359 | SUBDURAL HAEMORRHAGE |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 6746359 | FGN |
| 6746359 | HP |
| 6746359 | LIT |
Therapies reported
| no results found |